Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Positive association between plasma amylin and cognition in a homebound elderly population.

Qiu WQ, Au R, Zhu H, Wallack M, Liebson E, Li H, Rosenzweig J, Mwamburi M, Stern RA.

J Alzheimers Dis. 2014;42(2):555-63. doi: 10.3233/JAD-140210.

2.

Association between amylin and amyloid-β peptides in plasma in the context of apolipoprotein E4 allele.

Qiu WQ, Wallack M, Dean M, Liebson E, Mwamburi M, Zhu H.

PLoS One. 2014 Feb 10;9(2):e88063. doi: 10.1371/journal.pone.0088063. eCollection 2014.

3.

Intraperitoneal injection of the pancreatic peptide amylin potently reduces behavioral impairment and brain amyloid pathology in murine models of Alzheimer's disease.

Zhu H, Wang X, Wallack M, Li H, Carreras I, Dedeoglu A, Hur JY, Zheng H, Li H, Fine R, Mwamburi M, Sun X, Kowall N, Stern RA, Qiu WQ.

Mol Psychiatry. 2015 Feb;20(2):252-62. doi: 10.1038/mp.2014.17. Epub 2014 Mar 11.

4.

Plasma Amylin and Cognition in Diabetes in the Absence and the Presence of Insulin Treatment.

Qiu WQ, Li H, Zhu H, Scott T, Mwamburi M, Rosenberg I, Rosenzweig J.

J Diabetes Metab. 2014 Nov;5(11). pii: 458.

5.

Lack of association between apolipoprotein E genotypes and cognitive performance in the non-demented elderly.

Quintas JL, Souza VC, Henriques AD, Machado-Silva W, Toledo JO, Córdova C, Moraes CF, Camargos EF, Nóbrega OT.

Psychogeriatrics. 2014 Mar;14(1):11-6. doi: 10.1111/psyg.12029. Epub 2013 Oct 7.

6.

Characterization of insulin degrading enzyme and other amyloid-β degrading proteases in human serum: a role in Alzheimer's disease?

Liu Z, Zhu H, Fang GG, Walsh K, Mwamburi M, Wolozin B, Abdul-Hay SO, Ikezu T, Leissring MA, Qiu WQ.

J Alzheimers Dis. 2012;29(2):329-40. doi: 10.3233/JAD-2011-111472.

7.

Neuroprotective effects of the amylin analogue pramlintide on Alzheimer's disease pathogenesis and cognition.

Adler BL, Yarchoan M, Hwang HM, Louneva N, Blair JA, Palm R, Smith MA, Lee HG, Arnold SE, Casadesus G.

Neurobiol Aging. 2014 Apr;35(4):793-801. doi: 10.1016/j.neurobiolaging.2013.10.076. Epub 2013 Oct 11.

PMID:
24239383
8.

Age and apolipoprotein E genotype influence rate of cognitive decline in nondemented elderly.

Salmon DP, Ferris SH, Thomas RG, Sano M, Cummings JL, Sperling RA, Petersen RC, Aisen PS.

Neuropsychology. 2013 Jul;27(4):391-401. doi: 10.1037/a0032707.

9.

Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.

Jack CR Jr, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Mielke MM, Lowe VJ, Senjem ML, Gunter JL, Preboske GM, Pankratz VS, Vemuri P, Petersen RC.

Lancet Neurol. 2014 Oct;13(10):997-1005. doi: 10.1016/S1474-4422(14)70194-2. Epub 2014 Sep 4.

10.

Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease.

Wolk DA, Dickerson BC; Alzheimer's Disease Neuroimaging Initiative.

Proc Natl Acad Sci U S A. 2010 Jun 1;107(22):10256-61. doi: 10.1073/pnas.1001412107. Epub 2010 May 17.

11.

Increased brain activation during working memory in cognitively intact adults with the APOE epsilon4 allele.

Wishart HA, Saykin AJ, Rabin LA, Santulli RB, Flashman LA, Guerin SJ, Mamourian AC, Belloni DR, Rhodes CH, McAllister TW.

Am J Psychiatry. 2006 Sep;163(9):1603-10.

PMID:
16946187
12.

Interaction between testosterone and apolipoprotein E epsilon4 status on cognition in healthy older men.

Burkhardt MS, Foster JK, Clarnette RM, Chubb SA, Bruce DG, Drummond PD, Martins RN, Yeap BB.

J Clin Endocrinol Metab. 2006 Mar;91(3):1168-72. Epub 2005 Dec 20.

PMID:
16368754
13.

Memory performance in healthy elderly without Alzheimer's disease: effects of time and apolipoprotein-E.

Mayeux R, Small SA, Tang M, Tycko B, Stern Y.

Neurobiol Aging. 2001 Jul-Aug;22(4):683-9.

PMID:
11445269
14.

The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.

Marchant NL, Reed BR, Sanossian N, Madison CM, Kriger S, Dhada R, Mack WJ, DeCarli C, Weiner MW, Mungas DM, Chui HC, Jagust WJ.

JAMA Neurol. 2013 Apr;70(4):488-95. doi: 10.1001/2013.jamaneurol.405.

15.

Brain aging in normal Egyptians: cognition, education, personality, genetic and immunological study.

Elwan O, Madkour O, Elwan F, Mostafa M, Abbas Helmy A, Abdel-Naseer M, Abdel Shafy S, El Faiuomy N.

J Neurol Sci. 2003 Jul 15;211(1-2):15-22.

PMID:
12767492
16.

Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease.

Bizzarro A, Marra C, Acciarri A, Valenza A, Tiziano FD, Brahe C, Masullo C.

Dement Geriatr Cogn Disord. 2005;20(4):254-61. Epub 2005 Aug 9.

PMID:
16103669
17.

Association between cognitive function and plasma lipids of the elderly after controlling for apolipoprotein E genotype.

Yasuno F, Tanimukai S, Sasaki M, Hidaka S, Ikejima C, Yamashita F, Kodama C, Mizukami K, Michikawa M, Asada T.

Am J Geriatr Psychiatry. 2012 Jul;20(7):574-83. doi: 10.1097/JGP.0b013e318211819b.

PMID:
21407046
18.

Long-term post-operative cognitive decline in the elderly: the effects of anesthesia type, apolipoprotein E genotype, and clinical antecedents.

Ancelin ML, de Roquefeuil G, Scali J, Bonnel F, Adam JF, Cheminal JC, Cristol JP, Dupuy AM, Carrière I, Ritchie K.

J Alzheimers Dis. 2010;22 Suppl 3:105-13. doi: 10.3233/JAD-2010-100807.

19.

Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer's disease.

Lim YY, Maruff P, Pietrzak RH, Ames D, Ellis KA, Harrington K, Lautenschlager NT, Szoeke C, Martins RN, Masters CL, Villemagne VL, Rowe CC; AIBL Research Group.

Brain. 2014 Jan;137(Pt 1):221-31. doi: 10.1093/brain/awt286. Epub 2013 Oct 30.

20.

Cognitive asymmetries associated with apolipoprotein E genotype in patients with Alzheimer's disease.

Finton MJ, Lucas JA, Rippeth JD, Bohac DL, Smith GE, Ivnik RJ, Petersen RC, Graff-Radford NR.

J Int Neuropsychol Soc. 2003 Jul;9(5):751-9.

PMID:
12901781
Items per page

Supplemental Content

Write to the Help Desk